Search

Raymond J Henley Iii

Examiner (ID: 13341, Phone: (571)272-0575 , Office: P/1629 )

Most Active Art Unit
1614
Art Unit(s)
1205, 1614, 1629, 1621, 2899
Total Applications
4270
Issued Applications
3011
Pending Applications
581
Abandoned Applications
704

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16769738 [patent_doc_number] => 10980821 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-20 [patent_title] => Triphenylphosphonium-derivative compounds for eradicating cancer stem cells [patent_app_type] => utility [patent_app_number] => 16/766472 [patent_app_country] => US [patent_app_date] => 2018-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 5917 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766472 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/766472
Triphenylphosphonium-derivative compounds for eradicating cancer stem cells Nov 20, 2018 Issued
Array ( [id] => 16482351 [patent_doc_number] => 20200375951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => DANTROLENE AND ANALOGS THEREOF FOR THE CHRONIC TREATMENT AND PREVENTION OF DYSSYNCHRONOUS CARDIAC DYSFUNCTION [patent_app_type] => utility [patent_app_number] => 16/763914 [patent_app_country] => US [patent_app_date] => 2018-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10185 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763914 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/763914
Dantrolene and analogs thereof for the chronic treatment and prevention of dyssynchronous cardiac dysfunction Nov 13, 2018 Issued
Array ( [id] => 14435465 [patent_doc_number] => 20190175604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => EZH2 INHIBITORS FOR TREATING LYMPHOMA [patent_app_type] => utility [patent_app_number] => 16/181747 [patent_app_country] => US [patent_app_date] => 2018-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12913 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16181747 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/181747
EZH2 INHIBITORS FOR TREATING LYMPHOMA Nov 5, 2018 Abandoned
Array ( [id] => 16420504 [patent_doc_number] => 20200345702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-05 [patent_title] => METHOD FOR TREATING THALASSEMIA [patent_app_type] => utility [patent_app_number] => 16/758986 [patent_app_country] => US [patent_app_date] => 2018-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758986 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/758986
Method for treating thalassemia Oct 25, 2018 Issued
Array ( [id] => 14833185 [patent_doc_number] => 20190274993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => GLUTAMINASE INHIBITOR THERAPY [patent_app_type] => utility [patent_app_number] => 16/164581 [patent_app_country] => US [patent_app_date] => 2018-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35087 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16164581 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/164581
Glutaminase inhibitor therapy Oct 17, 2018 Issued
Array ( [id] => 17923019 [patent_doc_number] => 11466254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-11 [patent_title] => Composition containing, as active ingredient, culture of chicken bone marrow-derived osteochondral progenitor cells for promoting osteogenesis or inducing chondrogenic differentiation [patent_app_type] => utility [patent_app_number] => 16/757335 [patent_app_country] => US [patent_app_date] => 2018-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12000 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757335 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/757335
Composition containing, as active ingredient, culture of chicken bone marrow-derived osteochondral progenitor cells for promoting osteogenesis or inducing chondrogenic differentiation Oct 15, 2018 Issued
Array ( [id] => 16204753 [patent_doc_number] => 20200237743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => CRAC CHANNEL MODULATORS FOR TREATING ESOPHAGEAL CANCER [patent_app_type] => utility [patent_app_number] => 16/756077 [patent_app_country] => US [patent_app_date] => 2018-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9211 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756077 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/756077
CRAC CHANNEL MODULATORS FOR TREATING ESOPHAGEAL CANCER Oct 15, 2018 Abandoned
Array ( [id] => 16930777 [patent_doc_number] => 20210196666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => Compounds For Inhibiting Secretory Leukocyte Protease Inhibitor (SLPI) [patent_app_type] => utility [patent_app_number] => 16/754912 [patent_app_country] => US [patent_app_date] => 2018-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10198 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754912 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/754912
Compounds for inhibiting secretory leukocyte protease inhibitor (SLPI) Oct 8, 2018 Issued
Array ( [id] => 14712593 [patent_doc_number] => 20190247360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => Pharmaceutical Composition for Treating Bacterial and Viral infections [patent_app_type] => utility [patent_app_number] => 16/153589 [patent_app_country] => US [patent_app_date] => 2018-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1942 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16153589 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/153589
Pharmaceutical Composition for Treating Bacterial and Viral infections Oct 4, 2018 Abandoned
Array ( [id] => 16341586 [patent_doc_number] => 20200306236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => COMBINATION THERAPIES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/754083 [patent_app_country] => US [patent_app_date] => 2018-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22266 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754083 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/754083
Combination therapies and uses thereof Oct 4, 2018 Issued
Array ( [id] => 14403709 [patent_doc_number] => 20190167698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => Methods of Treating Certain Depressive Disorders and Delirium Tremens [patent_app_type] => utility [patent_app_number] => 16/150782 [patent_app_country] => US [patent_app_date] => 2018-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14027 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16150782 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/150782
Methods of treating certain depressive disorders and delirium tremens Oct 2, 2018 Issued
Array ( [id] => 14712521 [patent_doc_number] => 20190247324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => One or a Combination of Phyto-Cannabinoids in the Treatment of Epilepsy [patent_app_type] => utility [patent_app_number] => 16/149983 [patent_app_country] => US [patent_app_date] => 2018-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7087 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16149983 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/149983
One or a Combination of Phyto-Cannabinoids in the Treatment of Epilepsy Oct 1, 2018 Abandoned
Array ( [id] => 13867295 [patent_doc_number] => 20190029988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => EXTENDED DURATION LOCAL ANESTHETIC FORMULATION [patent_app_type] => utility [patent_app_number] => 16/148080 [patent_app_country] => US [patent_app_date] => 2018-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4955 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148080 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/148080
Extended duration local anesthetic formulation Sep 30, 2018 Issued
Array ( [id] => 16236683 [patent_doc_number] => 20200253917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH [patent_app_type] => utility [patent_app_number] => 16/651835 [patent_app_country] => US [patent_app_date] => 2018-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6817 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651835 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/651835
COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH Sep 27, 2018 Abandoned
Array ( [id] => 16612086 [patent_doc_number] => 20210030739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => COMPOSITIONS AND METHODS OF TREATING CANCER [patent_app_type] => utility [patent_app_number] => 16/649277 [patent_app_country] => US [patent_app_date] => 2018-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20747 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649277 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/649277
Compositions and methods of treating cancer Sep 27, 2018 Issued
Array ( [id] => 17602850 [patent_doc_number] => 11331319 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Combination treatment for neuropsychiatric disorders [patent_app_type] => utility [patent_app_number] => 16/651001 [patent_app_country] => US [patent_app_date] => 2018-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19607 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651001 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/651001
Combination treatment for neuropsychiatric disorders Sep 26, 2018 Issued
Array ( [id] => 18188571 [patent_doc_number] => 11579147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-14 [patent_title] => Use of VNN1 as a biomarker and a therapeutic target in sarcomas [patent_app_type] => utility [patent_app_number] => 16/649860 [patent_app_country] => US [patent_app_date] => 2018-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 11175 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649860 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/649860
Use of VNN1 as a biomarker and a therapeutic target in sarcomas Sep 24, 2018 Issued
Array ( [id] => 15571391 [patent_doc_number] => 10576053 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-03 [patent_title] => Composition containing eicosapentaenoic acid alkyl ester, and method for producing same [patent_app_type] => utility [patent_app_number] => 16/134140 [patent_app_country] => US [patent_app_date] => 2018-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14225 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16134140 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/134140
Composition containing eicosapentaenoic acid alkyl ester, and method for producing same Sep 17, 2018 Issued
Array ( [id] => 14594025 [patent_doc_number] => 10350187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-16 [patent_title] => Methods and composition for suppression of pathogenic bacterial growth, fungal growth, or microbial growth in or on skin [patent_app_type] => utility [patent_app_number] => 16/133793 [patent_app_country] => US [patent_app_date] => 2018-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 5181 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133793 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/133793
Methods and composition for suppression of pathogenic bacterial growth, fungal growth, or microbial growth in or on skin Sep 17, 2018 Issued
Array ( [id] => 14743821 [patent_doc_number] => 20190255084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => DIAGNOSTICS AND METHODS FOR TREATMENT OF NON-ALCOHOLIC HEPATIC STEATOSIS AND HEPATIC STEATOHEPATITIS, AND PREVENTION OF COMPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 16/133322 [patent_app_country] => US [patent_app_date] => 2018-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57695 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133322 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/133322
Diagnostics and methods for treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis, and prevention of complications thereof Sep 16, 2018 Issued
Menu